FDA
-
-
-
-
-
-
-
Seres Therapeutics secures $25 million from Nestle deal, cuts lease costs
-
-
-
-
-
-
-
Seres Therapeutics to Present at CARB-X Investor Day
-
-
-
-
-
-
-
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
-
-
-
-
-
-
-
Seres Therapeutics (MCRB) PT Raised to $22 at Canaccord Genuity
-
-
-
-
-
-
-
Seres Therapeutics Announces Leadership Transition
-
-
-
-
-
-
-
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
-
335,212 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


